Pattern Bioscience specializes in the rapid identification of bacterial infections and their antibiotic resistance profiles. The company uses advanced digital technology that combines single-cell analysis with AI pattern recognition to provide ID/AST results in just four hours, a significant reduction from traditional methods that can take days. Its primary customers are hospitals and healthcare providers, including lab directors and infection prevention specialists. Pattern Bioscience differentiates itself by offering faster and more accurate diagnostics, which helps reduce unnecessary antibiotic prescriptions and combat antibiotic resistance. The company's goal is to improve patient outcomes and address the global health threat posed by antibiotic misuse.